August 26, 2016 — The latest version of Elekta’s Monaco treatment planning software was recently highlighted in multiple presentations at the 58 th American Association of Physicists in Medicine (AAPM) annual meeting and exhibition, July 31-Aug. 4 in Washington, D.C.

Respiratory motion presents a number of challenges in the delivery of radiotherapy to certain thoracic or abdominal tumors. 

 As a further safety measure against the emerging Zika virus outbreak, the U.S. Food and Drug Administration issued a revised guidance recommending universal testing of donated Whole Blood and blood components for Zika virus in the U.S. and its territories.

The brain’s reward centers in severely obese women continue to respond to food cues even after they’ve eaten and are no longer hungry, in contrast to their lean counterparts, according to a recent study. 


The Radiological Society of North American (RSNA) journal Radiology has published a special report, detailing the spectrum of imaging findings in babies and fetuses infected with the Zika virus. The article includes a large number of ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) images of Zika virus patients during pre- and postnatal development, showing the profound effects of the disease. 


Hologic Inc. announced that a recent study shows Low Dose 3-D Mammography exams with C-View software are comparable to traditional Genius 3-D Mammography exams. The study, conducted by University of Pennsylvania researchers and published online in advance of print by Radiology, showed similar overall and invasive breast cancer detection, as well as recall rates.

Dune Medical Devices has been selected as one of the few recipients of a European Union Horizon 2020 research grant to spur development of its biopsy system. The 80 billion euro, seven-year program is aimed at securing Europe’s global competitiveness.

August 25, 2016 — National insurer Cigna revised its medical coverage policy for breast cancer screening and will now cover three-dimensional (3D) mammography for routine breast cancer screening. Under its previous policy, the company covered 3-D mammography for diagnostic purposes, but not for routine screening.

August 25, 2016 — Fujifilm Medical Systems U.S.A. has submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval (PMA) application for digital breast tomosynthesis (DBT), as an optional software upgrade for the Aspire  Cristalle digital mammography system.

The optional DBT 3-D mammography upgrade for the Aspire Cristalle system, known as Amulet Innovality outside of the United States, has been available since May 2013 in Europe, Asia and Latin America.

Subscribe Now